Efficacy of Shock Wave Therapy in Post-Stroke Muscle Spasticity Management
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Oviedo
About this trial
The goal of this clinical trial is to evaluate the efficacy and safety of shock wave therapy (SWT) in reducing muscle spasticity in patients who have suffered a stroke. The main questions it aims to answer are:
Does SWT reduce muscle tone and improve joint range of motion in post-stroke patients with spasticity? Does SWT improve the quality of life for these patients? What side effects, if any, occur during or after SWT? Researchers will compare SWT to conventional spasticity treatments to determine its effectiveness and potential advantages.
Participants will:
Undergo SWT sessions as part of their rehabilitation protocol over a period of 8 weeks.
Attend follow-up visits to assess muscle tone, joint mobility, and overall functional improvement.
Complete quality-of-life questionnaires to measure the therapy's impact on daily living.
Eligibility criteria
Qualifiers
Adults aged 18 years or older.
Confirmed diagnosis of stroke (ischemic or hemorrhagic) at least 6 months prior to enrollment.
Clinically diagnosed muscle spasticity, measured by the Modified Ashworth Scale (MAS), with a score of 0 to 3.
Stable medical condition that permits participation in the intervention.
Disqualifiers
Severe spasticity or contractures unresponsive to prior treatments.
Local infections in the treatment area.
Known or suspected malignancy near the treatment site.
Severe bleeding disorders or anticoagulation therapy.
Trial design
Treatments tested in this trial
- Shock Wave Therapy (SWT)
- Active Comparator - Conventional Therapy
Treatment groups
50 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov